Source: Annual Congress 2001 - Health status and management in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. K. Sont, J. Kievit, K. F. Rabe, P. J. Sterk (Leiden, The Netherlands). What clinical features underlying GINA step 1-4 drive the level of treatment in patients with asthma. Eur Respir J 2001; 16: Suppl. 31, 463

Member's Comments

No comment yet.

Related content which might interest you: Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study) Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015 Year: 2017 Clinical, inflammaory and functional analysis before, during and after treatment with Omalizumabe in patients with difficulty control asthma. Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (PBO)-controlled trials Source: International Congress 2016 – Asthma management Year: 2016 Uncontrolled asthma on GINA step 4-5 treatment increases healthcare utilization – report from the population-based OLIN-studies Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses Year: 2019 Budesonid/formoterol easyhaler: clinical efficiency and adherence to treatment in patients with partly controlled bronchial asthma (BA). Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 Characteristics of the uncontrolled asthmatic patients on GINA step 4 treatment in Korea Source: Annual Congress 2012 - Epidemiology of asthma Year: 2012 Efficacy of omalizumab in patients with moderate-to-severe allergic asthma that is poorly controlled on GINA (1998) treatment step 3 or 4 Source: Eur Respir J 2003; 22: Suppl. 45, 203s Year: 2003 A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Clinical features and functional parameters predict the probability of ACO in patients with asthma and COPD Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3 Source: International Congress 2016 – Phenotyping asthma Year: 2016 A new perspective on concepts of asthma severity and control Source: Eur Respir J 2008; 32: 545-554 Year: 2008 GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality? Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 Managing asthma patients: which outcomes matter? Source: Eur Respir Rev 2008; 17: 53-61 Year: 2008 Can asthma control test (ACT) replace a global assessment of asthma control according to GINA guidelines? Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 A network analysis of clinical characteristics of patients with COPD: partial results. Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients Year: 2018 Asthma control test: Cut off values of control according to GINA guideline and its ability to predict exacerbations and treatment decisions Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011 Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials Source: Eur Respir J, 53 (5) 1900599; 10.1183/13993003.00599-2019 Year: 2019